Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × GEN-1 × Clear all

NCT01118052 2018-01-11

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase 2 Completed

22 enrolled 8 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms